TOWA PHARMACEUTICAL CO., LTD.

Greenhouse gas emissions & sustainability report data

📊 Latest report period: 2022-04 to 2023-03🗂️ Report periods on file: 2022-04 to 2023-03

In its 2022-04 to 2023-03 reporting, TOWA PHARMACEUTICAL CO., LTD. disclosed greenhouse gas emissions of 77.6K t-CO2e. By scope: Scope 1: 29.9K t-CO2e; Scope 2: 47.7K t-CO2e; Scope 3: 1.0M t-CO2e. Figures are as stated in the company's own report and may use different boundaries, units or methods (for example market-based vs location-based Scope 2), so compare with care.

💨
GHG Emissions
77.6K t-CO2e
2022-04 to 2023-03
💧
Water Usage
743.9K m3
2022-04 to 2023-03
♻️
Waste
6.0K tons
2022-04 to 2023-03
⚙️
Energy Use
32.9K kl (crude oil equivalent)
2022-04 to 2023-03

📊 Emissions by Scope (2022-04 to 2023-03)

ScopeWhat it coversReported value
Scope 1Direct emissions from sources the company owns or controls (fuel combustion, company vehicles, process and fugitive emissions).29.9K t-CO2e
Scope 2Indirect emissions from purchased electricity, steam, heat and cooling.47.7K t-CO2e
Scope 3Other indirect emissions across the value chain (purchased goods, business travel, use of sold products, etc.).1.0M t-CO2e

New to scopes? Read Scope 1, 2 and 3 emissions explained and market-based vs location-based Scope 2.

✅ Reported Environmental Achievements

🎯 Climate & Sustainability Targets

🔜 Short-term

  • Achieve 17.5 billion tablets annual production capacity by FY2024.

📅 Medium-term

  • Reduce greenhouse gas emissions by 30% by FY2030 (compared to FY2021).
  • Achieve carbon neutrality by FY2050.

🔭 Long-term

  • Contribute to the Comprehensive Community Care System in Japan.

🌱 ESG Focus Areas

EnvironmentSocietyGovernance

⚠️ Challenges & Risks +

  • Supply chain disruptions due to quality issues in the generics industry.
  • Rising raw material and utilities costs.
  • Annual revision of drug prices.

📋 Report Information

Reporting Period: 2022-04 to 2023-03
Frameworks: IFRS Foundation’s International Integrated Reporting Framework, Japanese Ministry of Economy, Trade and Industry’s Guidance for Collaborative Value Creation 2.0, TCFD recommendations